RecallRadar

FDA Drug recall D-428-2013

Levoxyl (levothyroxine sodium) tablets, USP, 137 mcg, packaged in a) 100-count bottles (NDC 60793-857-01) and b) 1000-count bottles (NDC 60…

On 2013-05-29 the FDA classified a Class II recall of Levoxyl (levothyroxine sodium) tablets, USP, 137 mcg, packaged in a) 100-count bottles (NDC 60793-857-01) and b) 1000-count bottles (NDC 60… by King Legacy A Wholly Owned Subsidiary, citing subpotent Drug: The products were below specification for potency at the expiry stability point.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-428-2013
ClassificationClass II
Statusterminated
Initiated2013-04-30
Published2013-05-29
Last updated2026-09-13 11:51 UTC
CompanyKing Legacy A Wholly Owned Subsidiary
DistributionUS

Product

Levoxyl (levothyroxine sodium) tablets, USP, 137 mcg, packaged in a) 100-count bottles (NDC 60793-857-01) and b) 1000-count bottles (NDC 60793-857-10), Rx only, Manufactured and Distributed by: King Pharmaceuticals, Inc., Bristol, TN 37620

Reason

Subpotent Drug: The products were below specification for potency at the expiry stability point.

Identifiers

ndc60793-850-10
ndc60793-850-01
ndc60793-851-10
ndc60793-851-01
ndc60793-852-10
ndc60793-852-01
ndc60793-853-10
ndc60793-853-01
ndc60793-854-10
ndc60793-854-01
ndc60793-855-10
ndc60793-855-01
ndc60793-856-10
ndc60793-856-01
ndc60793-857-10
ndc60793-857-01
ndc60793-858-10
ndc60793-858-01
ndc60793-859-10
ndc60793-859-01
ndc60793-860-10
ndc60793-860-01
code_infoLot # a) 64190, Exp. 4/13; 64331, Exp. 6/13; 65642, Exp. 7/13; and 66297, Exp. 9/13; b) 64326, Exp. 4/13; 64332, Exp. 6/13; and 65771, Exp. 7/13

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-428-2013%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.